ArticleJournal of Alzheimer's disease : JAD2017
Living Alone with Alzheimer's Disease: Data from SveDem, the Swedish Dementia Registry.
Article in Journal of Alzheimer's disease : JAD, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05817188 (Translational Identification of Medication Repurposing Candidates to Slow Cognitive Decline in Dementia), which is not on this map. Cited by 30 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Translational Identification of Medication Repurposing Candidates to Slow Cognitive Decline in Dementia
Who cites it
30 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Mapping the global research landscape and trends of older people living alone: a bibliometric analysis.Frontiers in aging · 2025Pooled it
- Top five Alzheimer Disease trial eligibility criteria favor men compared to women in a clinic-based cohort.The journal of prevention of Alzheimer's disease · 2026Observational
- Living alone with dementia is a neglected source of inequality: findings from a scoping review of research evidence.Systematic reviews · 2025Article
- Prevalence of living alone with dementia and other progressive neurological conditions: findings from primary care data in England.BMC medicine · 2025Article
- Diagnostic Reversion in Dementia Care: A Real-World Analysis of Mild Cognitive Impairment Diagnoses Following Dementia in a Large Electronic Medical Record System.medRxiv : the preprint server for health sciences · 2025Article
- Association of Social Disconnection With the Incidence and Prognosis of Atrial Fibrillation: A Multistate Analysis.Journal of the American Heart Association · 2025Article
- Social Factors, Age, and Health at Time of Dementia Diagnosis.JAMA network open · 2025Article
- Costs of Care in Relation to Alzheimer's Disease Severity in Sweden: A National Registry-Based Cohort Study.PharmacoEconomics · 2025Article
- Characteristics, Needs, and Perspectives of Individuals Living Alone With Dementia: An Integrative Review.Health science reports · 2025Article
- High-risk medication use among older adults with cognitive impairment living alone in the United States.Journal of the American Geriatrics Society · 2024Article
- Prevalence of dementia diagnosis in Sweden by geographical region and sociodemographic subgroups: a nationwide observational study.The Lancet regional health. Europe · 2024Article
- Association of Family Support With Lower Modifiable Risk Factors for Dementia Among Cognitively Impaired Older Adults.The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry · 2024Article
- Hospital admissions and emergency department visits for people with dementia.QJM : monthly journal of the Association of Physicians · 2024Article
- Assessing Quality of Life, Economic Burden, and Independence Across the Alzheimer's Disease Continuum Using Patient-Caregiver Dyad Surveys.Journal of Alzheimer's disease : JAD · 2024Article
- Perceptions of the Role of Living Alone in Providing Services to Patients With Cognitive Impairment.JAMA network open · 2023Article
- Trends in Gender and Racial/Ethnic Disparities in Physical Disability and Social Support Among U.S. Older Adults With Cognitive Impairment Living Alone, 2000-2018.Innovation in aging · 2023Article
- AI-Assisted In-House Power Monitoring for the Detection of Cognitive Impairment in Older Adults.Sensors (Basel, Switzerland) · 2021Article
- Sex differences in the association of childhood socioeconomic position and later-life depressive symptoms in Europe: the mediating effect of education.Social psychiatry and psychiatric epidemiology · 2021Article
- Embarking on a memory assessment voices of older persons living with memory impairment.Dementia (London, England) · 2021Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMany people with Alzheimer's disease (AD) live alone in their own homes. There is a lack of knowledge about whether these individuals receive the same quality of diagnostics and treatment for AD as patients who are cohabiting.
objectivesTo investigate the diagnostic work-up and treatment of community-dwelling AD patients who live alone.
methodsWe performed a cross-sectional cohort study based on data from the Swedish Dementia Registry (SveDem). We studied patients diagnosed with AD between 2007 and 2015 (n = 26,163). Information about drugs and comorbidities was acquired from the Swedish Prescribed Drug Register and the Swedish Patient Register.
results11,878 (46%) patients lived alone, primarily older women. After adjusting for confounders, living alone was inversely associated with receiving computed tomography (OR 0.90; 95% CI 0.82-0.99), magnetic resonance imaging (OR 0.91; 95% CI 0.83-0.99), and lumbar puncture (OR 0.86; 95% CI 0.80-0.92). Living alone was also negatively associated with the use of cholinesterase inhibitors (OR 0.81; 95% CI 0.76; 0.87), memantine (OR 0.77; 95% CI 0.72; 0.83), and cardiovascular medication (OR 0.92; 0.86; 0.99). On the other hand, living alone was positively associated with the use of antidepressants (OR 1.15; 95% CI 1.08; 1.22), antipsychotics (OR 1.41; 95% CI 1.25; 1.58), and hypnotics and sedatives (OR 1.09; 95% CI 1.02; 1.17).
conclusionsSolitary living AD patients do not receive the same extent of care as those who are cohabiting.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.